Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X7MV
|
|||
| Drug Name |
Pyrrolidinyl urea derivative 1
|
|||
| Synonyms |
PMID26413912-Compound-52
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
JANSSEN PHARMACEUTICA NV BREITENBUCHER, Guy, J. TICHENOR, Mark, S. MERIT, Jeffrey, E. HAWRYLUK, Natalie, A. CHAMBERS, Alison, L. KEITH, John, M
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H24FN3O2
|
|||
| Canonical SMILES |
C1CN(CC1CCC2=CC(=CC=C2)OC3=CC=C(C=C3)F)C(=O)NC4=CN=CC=C4
|
|||
| InChI |
1S/C24H24FN3O2/c25-20-8-10-22(11-9-20)30-23-5-1-3-18(15-23)6-7-19-12-14-28(17-19)24(29)27-21-4-2-13-26-16-21/h1-5,8-11,13,15-16,19H,6-7,12,14,17H2,(H,27,29)
|
|||
| InChIKey |
BDZREAHMWOSTKO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.